image
Healthcare - Biotechnology - NASDAQ - US
$ 9.47
-6.24 %
$ 563 M
Market Cap
-2.62
P/E
BALANCE SHEET
423 M ASSETS
-17.54%
220 M LIABILITIES
-2.68%
203 M EQUITY
135.36%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition IGM Biosciences, Inc.
image
Current Assets 348 M
Cash & Short-Term Investments 338 M
Receivables 0
Other Current Assets 9.92 M
Non-Current Assets 75.8 M
Long-Term Investments 0
PP&E 74 M
Other Non-Current Assets 1.81 M
Current Liabilities 42.5 M
Accounts Payable 1.33 M
Short-Term Debt 11.7 M
Other Current Liabilities 29.5 M
Non-Current Liabilities 178 M
Long-Term Debt 34.7 M
Other Non-Current Liabilities 143 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
ASSETS
Cash & Cash Equivalents 112.5 121.2 133.3 241.1 35.9 1.9 0.4
Short Term Investments 225.2 305.9 96.2 125.2 188.7 0 0
Receivables 0 0 0 0 35 K 35 K 0
Inventory 0 0 0 0 (12.0) 0 0
Other Current Assets 9.9 21.3 11.2 14.0 6.4 0.5 0.2
Total Current Assets 347.6 438.4 240.7 373.3 231.1 2.4 0.7
PP&E 74.0 73.1 56.3 34.8 18.0 1.5 0.7
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 12.0 100 K 50 K
Other Long Term Assets 1.8 2.0 1.0 0.5 0.3 0 8 K
Other Assets 0 0 0 0 0 0 0
Total Assets 423.4 513.5 298.1 408.6 261.4 4.0 1.4
LIABILITIES
Accounts Payable 1.3 2.5 5.6 7.9 3.1 0.2 0.2
Short Term Debt 11.7 11.6 6.6 5.3 5.0 8.3 0
Other Current Liabilities 25.7 27.8 15.6 4.0 0.8 3.6 0.5
Total Current Liabilities 42.5 44.7 27.8 17.2 8.9 8.9 1.0
Long Term Debt 34.7 35.4 25.4 9.6 12.2 0 0
Deferred Tax Income 0 (146.2) 0 0 0 0 0
Other Liabilities 0 0 0 0 0 60.9 40.8
Total Liabilities 220.2 226.2 53.2 26.8 21.1 69.8 41.9
EQUITY
Common Stock 0.6 0.4 0.3 0.3 0.3 4 K 4 K
Retained Earnings (821.2) (574.8) (353.7) (188.6) (107.2) (64.1) (41.4)
Other Accumulative Comprehensive Income/Loss 0.2 (0.7) 66 K 26 K 43 K (0.7) (0.4)
Total Equity 203.2 (574.8) (353.7) (188.6) (107.2) (65.8) (40.5)
Total Liabilities and Equity 423.4 (348.6) (300.5) (161.7) (86.1) 4.0 1.4
SHARES OUTSTANDING
Common Shares Outstanding 52.3 41.5 33.5 30.7 9.0 0.4 0.4